发明名称 Apparatus and system for diabetes management
摘要 An apparatus and system diabetes management. The apparatus comprises a body which houses: (i) at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; (ii) a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen; (iii) a display screen operatively connected to the processor; (iv) a quantity of insulin; (v) a needle communicating with the quantity of insulin for delivering insulin to the patient; (vi) means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and (vii) metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle.
申请公布号 US8992464(B2) 申请公布日期 2015.03.31
申请号 US200913128358 申请日期 2009.11.11
申请人 Hygieia, Inc. 发明人 Bashan Eran;Hodish Israel
分类号 A61M31/00;G06F19/00;A61B5/145;A61B5/00 主分类号 A61M31/00
代理机构 Jones Day 代理人 Jones Day
主权项 1. An apparatus for diabetes management, the apparatus comprising: a body housing; at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times within a predetermined time interval whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen, wherein the predetermined time interval is longer than a time period between any two consecutive blood-glucose-level measurements, andwherein said determination occurs only after a passage of the predetermined time interval since the need to update the patient's insulin dosage regimen was last assessed or if urgent variation to the patient's present insulin dosage is necessary, and a display screen operatively connected to the processor; a quantity of insulin; a needle communicating with the quantity of insulin for delivering insulin to the patient; means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle.
地址 Ann Arbor MI US